Michael W. Cannon

Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399

Anthony J. Cmelak, Sigui Li, Meredith A. Goldwasser et al. · Journal of Clinical Oncology · 2007 · 145 citations · Full text

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

Ivana N. Micallef, Matthew J. Maurer, Gregory A. Wiseman et al. · Blood · 2011 · 135 citations · Full text

Randomized, Multicenter, Phase II Trial of Two Multicomponent Regimens in Androgen-Independent Prostate Cancer

Randall E. Millikan, Peter F. Thall, Sang Joon Lee et al. · Journal of Clinical Oncology · 2003 · 41 citations

Existential risk from AI and orthogonality: Can we have it both ways?

Vincent C. Müller, Michael W. Cannon · Ratio · 2021 · 33 citations · Full text

Artificial Intelligence, Cognitive Science, Existentialism +10

Phase II Study of Gemcitabine Plus Cisplatin in Patients With Metastatic Breast Cancer

Patrick A. Burch, James A. Mailliard, David W. Hillman et al. · American Journal of Clinical Oncology · 2005 · 31 citations